Aline Andres
Concepts (332)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Milk, Human | 19 | 2024 | 109 | 5.730 |
Why?
| Body Composition | 17 | 2024 | 318 | 4.870 |
Why?
| Breast Feeding | 24 | 2024 | 187 | 4.030 |
Why?
| Obesity | 28 | 2024 | 1113 | 4.020 |
Why?
| Adiposity | 9 | 2024 | 127 | 3.650 |
Why?
| Body Mass Index | 22 | 2024 | 652 | 3.550 |
Why?
| Weight Gain | 13 | 2023 | 240 | 3.110 |
Why?
| Pregnancy | 42 | 2024 | 2607 | 3.030 |
Why?
| Overweight | 11 | 2024 | 219 | 2.730 |
Why?
| Exercise | 9 | 2024 | 495 | 2.480 |
Why?
| Adipose Tissue | 7 | 2024 | 187 | 2.330 |
Why?
| Infant Formula | 18 | 2023 | 145 | 2.330 |
Why?
| Mothers | 6 | 2024 | 249 | 2.160 |
Why?
| Child Development | 9 | 2021 | 190 | 2.040 |
Why?
| Infant | 38 | 2024 | 3567 | 2.030 |
Why?
| Maternal Nutritional Physiological Phenomena | 6 | 2021 | 57 | 2.020 |
Why?
| Female | 78 | 2024 | 26472 | 1.870 |
Why?
| Oligosaccharides | 5 | 2024 | 33 | 1.770 |
Why?
| Breast Milk Expression | 2 | 2023 | 4 | 1.750 |
Why?
| Milk | 9 | 2023 | 85 | 1.740 |
Why?
| Pregnancy Complications | 10 | 2023 | 382 | 1.690 |
Why?
| Absorptiometry, Photon | 7 | 2023 | 154 | 1.570 |
Why?
| Insulin Resistance | 8 | 2021 | 264 | 1.510 |
Why?
| Plethysmography | 5 | 2020 | 43 | 1.440 |
Why?
| Humans | 86 | 2024 | 49974 | 1.380 |
Why?
| Longitudinal Studies | 15 | 2023 | 688 | 1.340 |
Why?
| Follicular Fluid | 2 | 2019 | 9 | 1.250 |
Why?
| Pregnant Women | 5 | 2022 | 77 | 1.220 |
Why?
| Cohort Studies | 14 | 2024 | 1422 | 1.220 |
Why?
| Infant Nutritional Physiological Phenomena | 7 | 2023 | 55 | 1.200 |
Why?
| Infant Food | 3 | 2020 | 29 | 1.190 |
Why?
| Bottle Feeding | 5 | 2020 | 34 | 1.180 |
Why?
| Diet | 13 | 2024 | 566 | 1.110 |
Why?
| Infant, Newborn | 22 | 2024 | 2772 | 1.110 |
Why?
| Postpartum Period | 4 | 2023 | 113 | 1.070 |
Why?
| Child, Preschool | 15 | 2024 | 3871 | 1.060 |
Why?
| Isoleucine | 2 | 2024 | 27 | 1.040 |
Why?
| Anthropometry | 6 | 2024 | 92 | 1.010 |
Why?
| Magnetic Resonance Spectroscopy | 2 | 2020 | 244 | 0.990 |
Why?
| Metabolome | 3 | 2020 | 89 | 0.960 |
Why?
| Child | 17 | 2024 | 6847 | 0.930 |
Why?
| Lipid Metabolism | 4 | 2019 | 175 | 0.880 |
Why?
| Growth | 3 | 2020 | 40 | 0.860 |
Why?
| Eating | 2 | 2021 | 162 | 0.850 |
Why?
| Prenatal Care | 3 | 2023 | 108 | 0.840 |
Why?
| Blood Glucose | 3 | 2020 | 439 | 0.840 |
Why?
| Adult | 26 | 2024 | 13236 | 0.830 |
Why?
| Sleep | 1 | 2023 | 184 | 0.810 |
Why?
| Pregnancy Trimester, First | 2 | 2023 | 22 | 0.790 |
Why?
| Homeostasis | 2 | 2020 | 200 | 0.780 |
Why?
| Monosaccharides | 1 | 2020 | 6 | 0.750 |
Why?
| Leptin | 3 | 2022 | 140 | 0.750 |
Why?
| Male | 34 | 2024 | 25241 | 0.750 |
Why?
| Dietary Proteins | 2 | 2020 | 242 | 0.720 |
Why?
| Parents | 2 | 2022 | 314 | 0.720 |
Why?
| Pregnancy Trimester, Third | 1 | 2020 | 65 | 0.720 |
Why?
| Maternal-Fetal Exchange | 1 | 2020 | 43 | 0.710 |
Why?
| Isoflavones | 4 | 2009 | 89 | 0.700 |
Why?
| Early Growth Response Protein 1 | 3 | 2016 | 35 | 0.680 |
Why?
| Body Weight | 3 | 2021 | 513 | 0.680 |
Why?
| Fertilization in Vitro | 1 | 2019 | 28 | 0.660 |
Why?
| Lactation | 4 | 2023 | 62 | 0.620 |
Why?
| Soy Milk | 6 | 2018 | 38 | 0.610 |
Why?
| Oocytes | 1 | 2017 | 74 | 0.570 |
Why?
| Directive Counseling | 1 | 2017 | 23 | 0.570 |
Why?
| Antioxidants | 1 | 2019 | 249 | 0.560 |
Why?
| Ovary | 2 | 2016 | 104 | 0.550 |
Why?
| C-Reactive Protein | 1 | 2017 | 142 | 0.550 |
Why?
| Triglycerides | 1 | 2017 | 159 | 0.540 |
Why?
| Prenatal Diagnosis | 1 | 2016 | 107 | 0.530 |
Why?
| Body Water | 2 | 2012 | 23 | 0.520 |
Why?
| Patient Compliance | 1 | 2017 | 230 | 0.510 |
Why?
| Sexual Development | 1 | 2015 | 6 | 0.510 |
Why?
| Genitalia, Male | 1 | 2015 | 13 | 0.510 |
Why?
| Soybean Proteins | 4 | 2020 | 161 | 0.500 |
Why?
| Behavior Therapy | 1 | 2017 | 181 | 0.500 |
Why?
| Soy Foods | 1 | 2015 | 20 | 0.500 |
Why?
| Genitalia, Female | 1 | 2015 | 18 | 0.500 |
Why?
| Child of Impaired Parents | 1 | 2015 | 41 | 0.500 |
Why?
| Oxidative Stress | 1 | 2019 | 770 | 0.470 |
Why?
| Animals | 18 | 2024 | 13187 | 0.450 |
Why?
| Feces | 3 | 2024 | 134 | 0.440 |
Why?
| Gestational Age | 4 | 2019 | 421 | 0.440 |
Why?
| Bone Density | 2 | 2023 | 379 | 0.420 |
Why?
| Infant Behavior | 1 | 2012 | 18 | 0.420 |
Why?
| Case-Control Studies | 4 | 2019 | 1131 | 0.390 |
Why?
| RNA, Ribosomal, 16S | 4 | 2024 | 113 | 0.380 |
Why?
| Military Personnel | 2 | 2023 | 159 | 0.380 |
Why?
| Umbilical Cord | 3 | 2017 | 35 | 0.370 |
Why?
| Insulin | 4 | 2022 | 457 | 0.360 |
Why?
| Cross-Sectional Studies | 3 | 2024 | 1557 | 0.360 |
Why?
| Feeding Behavior | 2 | 2024 | 181 | 0.360 |
Why?
| Young Adult | 7 | 2023 | 3958 | 0.360 |
Why?
| Risk Factors | 5 | 2023 | 3613 | 0.360 |
Why?
| Food Supply | 2 | 2023 | 91 | 0.350 |
Why?
| Phenotype | 3 | 2023 | 729 | 0.350 |
Why?
| Linear Models | 2 | 2021 | 280 | 0.350 |
Why?
| Magnetic Resonance Imaging | 3 | 2020 | 1537 | 0.340 |
Why?
| Viruses | 1 | 2009 | 21 | 0.340 |
Why?
| Virus Diseases | 1 | 2009 | 39 | 0.330 |
Why?
| Rotavirus | 2 | 2009 | 9 | 0.320 |
Why?
| Antiviral Agents | 1 | 2009 | 173 | 0.300 |
Why?
| Speech Perception | 3 | 2016 | 89 | 0.300 |
Why?
| Inflammation | 3 | 2017 | 604 | 0.300 |
Why?
| Breast | 2 | 2023 | 85 | 0.290 |
Why?
| Placenta | 2 | 2020 | 132 | 0.260 |
Why?
| Interleukin-8 | 2 | 2024 | 87 | 0.260 |
Why?
| Diffusion Tensor Imaging | 3 | 2023 | 91 | 0.250 |
Why?
| Heart | 2 | 2020 | 326 | 0.240 |
Why?
| Vagus Nerve | 2 | 2015 | 23 | 0.240 |
Why?
| DNA Methylation | 2 | 2020 | 548 | 0.240 |
Why?
| Arkansas | 4 | 2020 | 1977 | 0.230 |
Why?
| Prospective Studies | 5 | 2023 | 2364 | 0.230 |
Why?
| Evoked Potentials | 2 | 2016 | 72 | 0.230 |
Why?
| Fast Foods | 1 | 2023 | 12 | 0.230 |
Why?
| Sodium, Dietary | 1 | 2023 | 26 | 0.220 |
Why?
| Birth Weight | 2 | 2015 | 120 | 0.220 |
Why?
| Amino Acids, Branched-Chain | 2 | 2021 | 38 | 0.220 |
Why?
| Immunity, Innate | 1 | 2024 | 104 | 0.220 |
Why?
| Matrix Attachment Region Binding Proteins | 1 | 2023 | 34 | 0.220 |
Why?
| Intention | 1 | 2023 | 43 | 0.210 |
Why?
| Metabolomics | 2 | 2020 | 126 | 0.210 |
Why?
| Accelerometry | 1 | 2022 | 9 | 0.210 |
Why?
| Hypersensitivity | 1 | 2023 | 77 | 0.210 |
Why?
| Bone Diseases, Metabolic | 1 | 2023 | 74 | 0.210 |
Why?
| Diet, High-Fat | 3 | 2020 | 222 | 0.210 |
Why?
| Follow-Up Studies | 3 | 2019 | 2182 | 0.210 |
Why?
| Educational Status | 1 | 2023 | 222 | 0.200 |
Why?
| Lipids | 1 | 2022 | 147 | 0.200 |
Why?
| Immunoglobulin A | 1 | 2021 | 45 | 0.200 |
Why?
| Depressive Disorder, Major | 1 | 2023 | 151 | 0.200 |
Why?
| Metabolic Networks and Pathways | 2 | 2019 | 89 | 0.200 |
Why?
| Antibodies, Viral | 1 | 2021 | 88 | 0.200 |
Why?
| Leucine | 1 | 2021 | 116 | 0.190 |
Why?
| Predictive Value of Tests | 2 | 2016 | 903 | 0.190 |
Why?
| Urinalysis | 1 | 2020 | 34 | 0.190 |
Why?
| Cattle | 3 | 2020 | 210 | 0.180 |
Why?
| Adolescent | 3 | 2019 | 6356 | 0.180 |
Why?
| Body Fat Distribution | 1 | 2020 | 9 | 0.180 |
Why?
| Body Weights and Measures | 1 | 2020 | 17 | 0.180 |
Why?
| Models, Biological | 2 | 2020 | 727 | 0.180 |
Why?
| Brain | 6 | 2023 | 1328 | 0.180 |
Why?
| Physical Conditioning, Animal | 1 | 2020 | 52 | 0.180 |
Why?
| Health Status | 2 | 2020 | 298 | 0.170 |
Why?
| Transcriptome | 3 | 2018 | 315 | 0.170 |
Why?
| Health Behavior | 1 | 2022 | 254 | 0.170 |
Why?
| Exercise Therapy | 1 | 2020 | 98 | 0.170 |
Why?
| Insulin-Like Growth Factor I | 1 | 2019 | 137 | 0.170 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2020 | 349 | 0.160 |
Why?
| Sex Factors | 4 | 2018 | 691 | 0.160 |
Why?
| Uric Acid | 1 | 2019 | 21 | 0.160 |
Why?
| GABAergic Neurons | 1 | 2018 | 10 | 0.160 |
Why?
| Diabetes, Gestational | 1 | 2019 | 53 | 0.160 |
Why?
| Feasibility Studies | 1 | 2020 | 375 | 0.160 |
Why?
| Purines | 1 | 2018 | 38 | 0.160 |
Why?
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 181 | 0.160 |
Why?
| Exosomes | 1 | 2018 | 49 | 0.160 |
Why?
| Maternal Exposure | 1 | 2018 | 86 | 0.150 |
Why?
| Pilot Projects | 1 | 2020 | 699 | 0.150 |
Why?
| Adipogenesis | 2 | 2016 | 51 | 0.150 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2020 | 549 | 0.150 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2016 | 595 | 0.150 |
Why?
| Oocyte Retrieval | 1 | 2017 | 5 | 0.150 |
Why?
| Chemokine CXCL2 | 1 | 2017 | 12 | 0.150 |
Why?
| Ovulation Induction | 1 | 2017 | 10 | 0.150 |
Why?
| Inhibitor of Differentiation Proteins | 1 | 2017 | 6 | 0.150 |
Why?
| Dual Specificity Phosphatase 1 | 1 | 2017 | 9 | 0.150 |
Why?
| Fatty Liver | 1 | 2018 | 127 | 0.150 |
Why?
| Gene Expression Profiling | 3 | 2017 | 1032 | 0.140 |
Why?
| Parity | 1 | 2017 | 50 | 0.140 |
Why?
| Ideal Body Weight | 1 | 2017 | 6 | 0.140 |
Why?
| Friends | 1 | 2017 | 17 | 0.140 |
Why?
| Single-Cell Analysis | 1 | 2017 | 57 | 0.140 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2016 | 388 | 0.140 |
Why?
| Organ Size | 2 | 2015 | 226 | 0.140 |
Why?
| Sequence Analysis, RNA | 1 | 2017 | 91 | 0.140 |
Why?
| Receptors, Interleukin-8A | 1 | 2016 | 6 | 0.140 |
Why?
| Chemokine CXCL11 | 1 | 2016 | 6 | 0.140 |
Why?
| Amino Acids | 1 | 2019 | 360 | 0.140 |
Why?
| Granulosa Cells | 1 | 2016 | 12 | 0.140 |
Why?
| Versicans | 1 | 2016 | 10 | 0.140 |
Why?
| Glucose Transporter Type 4 | 1 | 2016 | 23 | 0.140 |
Why?
| Chemokine CXCL10 | 1 | 2016 | 19 | 0.140 |
Why?
| Monosaccharide Transport Proteins | 1 | 2016 | 14 | 0.140 |
Why?
| Tissue Array Analysis | 1 | 2016 | 45 | 0.140 |
Why?
| Sex Characteristics | 2 | 2018 | 190 | 0.140 |
Why?
| Receptors, CCR2 | 1 | 2016 | 14 | 0.140 |
Why?
| Food, Formulated | 2 | 2023 | 42 | 0.140 |
Why?
| Immunoblotting | 1 | 2016 | 118 | 0.140 |
Why?
| Guidelines as Topic | 1 | 2017 | 111 | 0.140 |
Why?
| Chemokine CCL2 | 1 | 2016 | 70 | 0.130 |
Why?
| Phosphoproteins | 1 | 2016 | 107 | 0.130 |
Why?
| RNA, Messenger | 2 | 2016 | 1105 | 0.130 |
Why?
| Family | 1 | 2017 | 170 | 0.130 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 157 | 0.130 |
Why?
| Rats, Sprague-Dawley | 2 | 2016 | 1597 | 0.130 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 141 | 0.130 |
Why?
| Nerve Tissue Proteins | 1 | 2017 | 193 | 0.130 |
Why?
| Carrier Proteins | 1 | 2017 | 304 | 0.130 |
Why?
| Cerebral Cortex | 1 | 2016 | 200 | 0.130 |
Why?
| Tissue Plasminogen Activator | 1 | 2016 | 109 | 0.130 |
Why?
| Ultrasonography | 2 | 2015 | 436 | 0.130 |
Why?
| Neoplasm Proteins | 1 | 2017 | 322 | 0.120 |
Why?
| Premature Birth | 1 | 2017 | 147 | 0.120 |
Why?
| MicroRNAs | 1 | 2018 | 353 | 0.120 |
Why?
| Up-Regulation | 1 | 2016 | 452 | 0.120 |
Why?
| Autonomic Nervous System | 1 | 2015 | 57 | 0.120 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2020 | 477 | 0.120 |
Why?
| Gene Expression Regulation | 2 | 2020 | 976 | 0.120 |
Why?
| Prognosis | 1 | 2019 | 1942 | 0.120 |
Why?
| Time Factors | 1 | 2020 | 2903 | 0.110 |
Why?
| Immunohistochemistry | 1 | 2016 | 973 | 0.110 |
Why?
| Deuterium Oxide | 1 | 2012 | 7 | 0.110 |
Why?
| Air | 1 | 2012 | 23 | 0.110 |
Why?
| Liver | 1 | 2018 | 1115 | 0.110 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2017 | 488 | 0.100 |
Why?
| Bacteria | 3 | 2022 | 224 | 0.100 |
Why?
| Life Style | 2 | 2023 | 140 | 0.100 |
Why?
| Disease Susceptibility | 1 | 2012 | 89 | 0.100 |
Why?
| Electroencephalography | 3 | 2023 | 306 | 0.100 |
Why?
| Swine | 2 | 2010 | 393 | 0.100 |
Why?
| Mice, Inbred C57BL | 3 | 2024 | 1816 | 0.100 |
Why?
| Cell Differentiation | 1 | 2014 | 651 | 0.100 |
Why?
| Evoked Potentials, Auditory | 1 | 2011 | 101 | 0.090 |
Why?
| Sensitivity and Specificity | 1 | 2012 | 861 | 0.090 |
Why?
| Mice | 4 | 2024 | 5739 | 0.090 |
Why?
| Calibration | 1 | 2010 | 58 | 0.090 |
Why?
| United States | 2 | 2020 | 4860 | 0.090 |
Why?
| Genitalia | 1 | 2009 | 11 | 0.090 |
Why?
| Radionuclide Imaging | 1 | 2010 | 116 | 0.090 |
Why?
| Phytoestrogens | 1 | 2009 | 22 | 0.090 |
Why?
| Anticarcinogenic Agents | 1 | 2009 | 34 | 0.080 |
Why?
| Genistein | 1 | 2009 | 47 | 0.080 |
Why?
| Cell Line | 2 | 2013 | 1000 | 0.080 |
Why?
| Flavonoids | 1 | 2009 | 58 | 0.080 |
Why?
| Biological Availability | 1 | 2009 | 122 | 0.080 |
Why?
| Species Specificity | 1 | 2009 | 192 | 0.080 |
Why?
| Reproducibility of Results | 1 | 2012 | 1193 | 0.080 |
Why?
| Gastrointestinal Tract | 1 | 2009 | 103 | 0.080 |
Why?
| Palmitates | 2 | 2022 | 29 | 0.080 |
Why?
| Gastrointestinal Diseases | 1 | 2009 | 126 | 0.080 |
Why?
| Rifabutin | 1 | 2007 | 5 | 0.080 |
Why?
| Lactams, Macrocyclic | 1 | 2007 | 14 | 0.080 |
Why?
| Benzoquinones | 1 | 2007 | 29 | 0.080 |
Why?
| Microscopy, Electron, Transmission | 1 | 2007 | 75 | 0.070 |
Why?
| Etoposide | 1 | 2007 | 72 | 0.070 |
Why?
| Analysis of Variance | 3 | 2014 | 562 | 0.070 |
Why?
| Estradiol | 1 | 2007 | 225 | 0.070 |
Why?
| Regression Analysis | 2 | 2017 | 395 | 0.060 |
Why?
| Bifidobacterium | 1 | 2024 | 7 | 0.060 |
Why?
| Disease Models, Animal | 1 | 2009 | 1455 | 0.060 |
Why?
| Language Development | 2 | 2016 | 28 | 0.060 |
Why?
| Leukocytes, Mononuclear | 1 | 2024 | 116 | 0.060 |
Why?
| Immune System | 1 | 2024 | 44 | 0.060 |
Why?
| Food Handling | 1 | 2023 | 33 | 0.060 |
Why?
| Vitamins | 1 | 2023 | 64 | 0.060 |
Why?
| Alkaline Phosphatase | 1 | 2023 | 94 | 0.060 |
Why?
| Lymphocytes | 1 | 2024 | 152 | 0.050 |
Why?
| Osteocalcin | 1 | 2023 | 43 | 0.050 |
Why?
| Syndrome | 1 | 2023 | 237 | 0.050 |
Why?
| Nutritional Status | 1 | 2023 | 141 | 0.050 |
Why?
| Energy Intake | 1 | 2023 | 170 | 0.050 |
Why?
| Nutrition Surveys | 1 | 2023 | 104 | 0.050 |
Why?
| Butyrates | 1 | 2022 | 30 | 0.050 |
Why?
| Immunization, Passive | 1 | 2021 | 29 | 0.050 |
Why?
| Gene Expression | 1 | 2024 | 609 | 0.050 |
Why?
| Carnitine | 1 | 2022 | 62 | 0.050 |
Why?
| Weight Loss | 1 | 2023 | 237 | 0.050 |
Why?
| Self Report | 1 | 2022 | 196 | 0.050 |
Why?
| RNA, Viral | 1 | 2021 | 125 | 0.050 |
Why?
| Phonetics | 2 | 2011 | 45 | 0.050 |
Why?
| Health Promotion | 1 | 2023 | 271 | 0.050 |
Why?
| Age Factors | 2 | 2014 | 1087 | 0.050 |
Why?
| Electric Impedance | 1 | 2020 | 41 | 0.040 |
Why?
| Optical Imaging | 1 | 2020 | 25 | 0.040 |
Why?
| National Institutes of Health (U.S.) | 1 | 2020 | 46 | 0.040 |
Why?
| Transcription Factors | 1 | 2023 | 561 | 0.040 |
Why?
| Bone and Bones | 1 | 2023 | 469 | 0.040 |
Why?
| CpG Islands | 1 | 2020 | 108 | 0.040 |
Why?
| Energy Metabolism | 1 | 2022 | 282 | 0.040 |
Why?
| Language | 1 | 2020 | 133 | 0.040 |
Why?
| Biodiversity | 1 | 2018 | 38 | 0.040 |
Why?
| Metagenomics | 1 | 2018 | 38 | 0.040 |
Why?
| Metagenome | 1 | 2018 | 41 | 0.040 |
Why?
| Community-Based Participatory Research | 1 | 2020 | 199 | 0.040 |
Why?
| Depression | 1 | 2023 | 568 | 0.040 |
Why?
| Bile Acids and Salts | 1 | 2018 | 75 | 0.040 |
Why?
| Phylogeny | 1 | 2018 | 235 | 0.040 |
Why?
| RNA | 1 | 2018 | 170 | 0.040 |
Why?
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2017 | 8 | 0.040 |
Why?
| Mice, Knockout | 1 | 2020 | 841 | 0.040 |
Why?
| AMP-Activated Protein Kinases | 1 | 2017 | 30 | 0.040 |
Why?
| Myocardium | 1 | 2020 | 436 | 0.040 |
Why?
| Thinness | 1 | 2016 | 46 | 0.030 |
Why?
| Skull | 1 | 2016 | 75 | 0.030 |
Why?
| Thiazolidinediones | 1 | 2016 | 82 | 0.030 |
Why?
| Anisotropy | 1 | 2015 | 63 | 0.030 |
Why?
| Child Language | 1 | 2014 | 11 | 0.030 |
Why?
| Intelligence Tests | 1 | 2014 | 44 | 0.030 |
Why?
| Intelligence | 1 | 2014 | 59 | 0.030 |
Why?
| Proteins | 1 | 2017 | 342 | 0.030 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 61 | 0.030 |
Why?
| Glucose | 1 | 2016 | 344 | 0.030 |
Why?
| Culture Media | 1 | 2014 | 94 | 0.030 |
Why?
| Microarray Analysis | 1 | 2014 | 73 | 0.030 |
Why?
| DNA Primers | 1 | 2014 | 207 | 0.030 |
Why?
| Cell Adhesion Molecules | 1 | 2014 | 88 | 0.030 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2014 | 123 | 0.030 |
Why?
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 90 | 0.030 |
Why?
| Osteogenesis | 1 | 2016 | 352 | 0.030 |
Why?
| Activating Transcription Factor 3 | 1 | 2013 | 8 | 0.030 |
Why?
| Trophoblasts | 1 | 2013 | 29 | 0.030 |
Why?
| Genotype | 1 | 2014 | 537 | 0.030 |
Why?
| Neuropsychological Tests | 1 | 2014 | 353 | 0.030 |
Why?
| Serum Response Factor | 1 | 2013 | 42 | 0.030 |
Why?
| Cells, Cultured | 1 | 2016 | 1573 | 0.030 |
Why?
| Blotting, Western | 1 | 2014 | 601 | 0.030 |
Why?
| MAP Kinase Signaling System | 1 | 2013 | 119 | 0.030 |
Why?
| Cell Proliferation | 1 | 2016 | 1007 | 0.030 |
Why?
| Interleukin-6 | 1 | 2013 | 264 | 0.020 |
Why?
| Milk Substitutes | 1 | 2010 | 6 | 0.020 |
Why?
| Speech Acoustics | 1 | 2010 | 18 | 0.020 |
Why?
| Diarrhea, Infantile | 1 | 2009 | 5 | 0.020 |
Why?
| Rats | 1 | 2016 | 3305 | 0.020 |
Why?
| Rotavirus Infections | 1 | 2009 | 6 | 0.020 |
Why?
| Single-Blind Method | 1 | 2009 | 116 | 0.020 |
Why?
| Signal Transduction | 1 | 2016 | 1618 | 0.020 |
Why?
| Testis | 1 | 2009 | 69 | 0.020 |
Why?
| Uterus | 1 | 2009 | 94 | 0.020 |
Why?
| Prostate | 1 | 2009 | 117 | 0.020 |
Why?
| Bone Development | 1 | 2009 | 65 | 0.020 |
Why?
| Animals, Newborn | 1 | 2009 | 367 | 0.020 |
Why?
|
|
Andres's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|